Analysis of Pulmonary Function between E-Cigarette Users and Non-Smokers Aged 20–30 Years in Jakarta

Authors

  • Reza Aditya Digambiro Department of Anatomical Pathology, Faculty of Medicine, Universitas Trisakti, Jakarta https://orcid.org/0000-0003-4692-7648
  • Edy Parwanto Department of Biology, Faculty of Medicine, Universitas Trisakti, Jakarta https://orcid.org/0000-0002-0797-6925
  • David Tjahjadi Department of Histology, Faculty of Medicine, Universitas Trisakti, Jakarta
  • Ditriana Ditriana Balaraja General Hospital, Tangerang, Banten

DOI:

https://doi.org/10.36497/jri.v45i2.791

Keywords:

e-cigarette, pulmonary function, respiratory health, spirometry, young adults

Abstract

Background: This study aimed to compare pulmonary function between e-cigarette users and non-smokers aged 20–30 years in Jakarta.

Methods: A cross-sectional study was carried out between May 2023 and May 2024 at SMC Clinic Jakarta, Ibnusina Hospital Jakarta, and Naura Medika Clinic Depok. The sample consisted of 65 individuals who used e-cigarettes and 63 individuals who did not smoke. Spirometry was employed to evaluate pulmonary function by measuring forced expiratory volume in 1 second (FEV1), forced vital capacity (FVC), and the FEV1/FVC ratio. The data were analyzed using independent t-tests using IBM SPSS software version 25.0.

Results: The study revealed substantial disparities in pulmonary function between individuals who use e-cigarettes and those who do not smoke. Individuals who use e-cigarettes had significantly reduced FEV1 at 3.02±0.50 L and FVC at 4.00±0.47 L, in comparison to non-smokers (FEV1=3.51±0.57 L; FVC=4.57±0.50 L). E-cigarette users exhibited a considerably lower FEV1/FVC ratio (74.86±5.55) compared to non-smokers (79.29±5.11), suggesting a higher occurrence of obstructive airway diseases.

Conclusion: Young adults aged 20-30 years in Jakarta who use e-cigarettes experience a decrease in pulmonary function. The results emphasize the possible respiratory hazards associated with the use of e-cigarettes and emphasize the necessity for greater awareness and regulatory actions to tackle these hazards.

Downloads

Download data is not yet available.

Author Biographies

  • Reza Aditya Digambiro, Department of Anatomical Pathology, Faculty of Medicine, Universitas Trisakti, Jakarta

    Dr. Reza Aditya Digambiro serves as a distinguished member of the Faculty of Medicine at Universitas Trisakti, situated at Jl Kyai Tapa No.260, Grogol, Jakarta Barat, DKI Jakarta, Indonesia. Engaged in pivotal research and academic pursuits, Dr. Digambiro is recognized for his expertise and significant contributions to the field of medicine. His relentless efforts towards advancing medical science are evident in the range of research projects he has been involved in. For further collaboration or scholarly correspondence, Dr. Digambiro can be reached at drdigambiro@trisakti.ac.id or contacted via phone at +628216650998 or +62 21 5660706 (Phone/Fax).

  • Edy Parwanto, Department of Biology, Faculty of Medicine, Universitas Trisakti, Jakarta

    Dr Edy Parwanto, M.Biomed

    Department of Biology - Faculty of Medicine - Universitas Trisakti

  • David Tjahjadi, Department of Histology, Faculty of Medicine, Universitas Trisakti, Jakarta

    dr.David Tjahjadi , M.Kes

    Department of Histology – Faculty of Medicine – Universitas Trisakti

  • Ditriana Ditriana, Balaraja General Hospital, Tangerang, Banten

    Department of Pulmonary Disease

    RSUD Balaraja , Tangerang, banten, Indonesia

References

1. Virgili F, Nenna R, Ben David S, Mancino E, Di Mattia G, Matera L, et al. E-cigarettes and youth: an unresolved Public Health concern. Ital J Pediatr. 2022;48(1):97.

2. Digambiro RA, Armielia AA, Abadi YB. Makanan dan gaya hidupmu penyebab kanker? 1st ed. Masruroh A, editor. Kabupaten Bandung: Widina Media Utama; 2023. 5–60 p.

3. Kislev MM, Kislev S. The market trajectory of a radically new product: e-cigarettes. Int J Mark Stud. 2020;12(4):63–92.

4. Mathur A, Dempsey OJ. Electronic cigarettes: a brief update. J R Coll Physicians Edinb. 2018;48(4):346–51.

5. Tjahyadi D, Parwanto E, Amalia H, Digambiro RA, Edy HJ, Oladimeji AV. Decreased density of pyramidal cells in the cerebral cortex, and Purkinje cells in the cerebellar cortex of Sprague-Dawley rats after being exposed to filtered kretek cigarette smoke. J Biol Res. 2023;96(1):10757.

6. Taylor A, Dunn K, Turfus S. A review of nicotine-containing electronic cigarettes—trends in use, effects, contents, labelling accuracy and detection methods. Drug Test Anal. 2021;13(2):242–60.

7. Wold LE, Tarran R, Crotty Alexander LE, Hamburg NM, Kheradmand F, St. Helen G, et al. Cardiopulmonary consequences of vaping in adolescents: a scientific statement from the American Heart Association. Circ Res. 2022;131(3):e70–82.

8. Thirion-Romero I, Pérez-Padilla R, Zabert G, Barrientos-Gutierrez I. Respiratory impact of electronic cigarettes and low-risk tobacco. Rev Invest Clin. 2019;71(1):17–27.

9. Gotts JE, Jordt SE, McConnell R, Tarran R. What are the respiratory effects of e-cigarettes? BMJ. 2019;366:l5275.

10. Chaiton M, Pienkowski M, Musani I, Bondy SJ, Cohen JE, Dubray J, et al. Smoking, e-cigarettes and the effect on respiratory symptoms among a population sample of youth: retrospective cohort study. Tob Induc Dis. 2023;21:08.

11. Digambiro RA, Parwanto E, Ilona F, Chendrasari J, Lestari IW, Ayu D, et al. Analisis konsentrasi partikel mikro ambient pada fungsi paru populasi urban Jakarta. Jurnal Akta Trimedika. 2024;1(1):41–51.

12. Kakavas S, Kotsiou OS, Perlikos F, Mermiri M, Mavrovounis G, Gourgoulianis K, et al. Pulmonary function testing in COPD: looking beyond the curtain of FEV1. NPJ Prim Care Respir Med. 2021;31(1):23.

13. Dugral E, Balkanci D, Ekizoglu O. Effects of smoking and physical exercise on respiratory function test results in students of university: a cross-sectional study. Medicine (Baltimore). 2019;98(32):e16596.

14. Polosa R, Morjaria JB, Prosperini U, Busà B, Pennisi A, Gussoni G, et al. Health outcomes in COPD smokers using heated tobacco products: a 3-year follow-up. Intern Emerg Med. 2021;16(3):687–96.

15. Digambiro RA, Parwanto E. Pedoman penelitian kanker. 1st ed. Andriyanto, editor. Klaten: Lakeisha; 2024. 1–151 p.

16. Joshi D, Duong M, Kirkland S, Raina P. Impact of electronic cigarette ever use on lung function in adults aged 45-85: a cross-sectional analysis from the Canadian Longitudinal Study on Aging. BMJ Open. 2021;11(10):e051519.

17. Gugala E, Okoh CM, Ghosh S, Moczygemba LR. Pulmonary health effects of electronic cigarettes: a scoping review. Health Promot Pract. 2022;23(3):388–96.

18. Torén K, Schiöler L, Lindberg A, Andersson A, Behndig AF, Bergström G, et al. The ratio FEV1/FVC and its association to respiratory symptoms—a Swedish general population study. Clin Physiol Funct Imaging. 2021;41(2):181–91.

19. Ponce MC, Sankari A, Sharma S. Pulmonary function tests. StatPearls, editor. StatPearls [Internet]. Treasure Island (FL). Treasure Island (FL): StatPearls Publishing; 2023. 12–50 p.

20. Simanjuntak AM, Hutapea A, Tampubolon BS, Browlim S, Napitupulu YP, Siregar IE, et al. Current developments of smoking and vaping, is vaping safer? JR. 2023;9(2):159–68.

21. Garavaglia ML, Bodega F, Porta C, Milzani A, Sironi C, Dalle-Donne I. Molecular impact of conventional and electronic cigarettes on pulmonary surfactant. Int J Mol Sci. 2023;24(14):11702.

22. Suryadinata R V., Wirjatmadi B. The molecular pathways of lung damage by e-cigarettes in male wistar rats. Sultan Qaboos Univ Med J. 2021;21(3):436–41.

23. Sinha D, Vishal, Kumar A, Khan M, Kumari R, Kesari M. Evaluation of tumor necrosis factor-alpha (TNF-α) and interleukin (IL)-1β levels among subjects vaping e-cigarettes and nonsmokers. J Family Med Prim Care. 2020;9(2):1072–5.

24. Kalan ME, Lazard AJ, Sheldon JM, Whitesell C, Hall MG, Ribisl KM, et al. Terms tobacco users employ to describe e-cigarette aerosol. Tob Control. 2022;33(1):15–20.

25. Al-tameemi S, Hameed N, Gomes K, Abid H. Cigarette smoking increases plasma levels of IL-6 and TNF-α. Baghdad Journal of Biochemistry and Applied Biological Sciences. 2022;3(1):60–8.

26. Yu H, Lin L, Zhang Z, Zhang H, Hu H. Targeting NF-κB pathway for the therapy of diseases: mechanism and clinical study. Signal Transduct Target Ther. 2020;5(1):209.

27. Albensi BC. What is nuclear factor kappa B (NF-κB) doing in and to the mitochondrion? Front Cell Dev Biol. 2019;7:154.

Downloads

Published

2025-04-20

Issue

Vol. 45 No. 2 (2025)

Section

Original Article

License

Copyright (c) 2025 Reza Aditya Digambiro, Edy Parwanto, David Tjahjadi, Ditriana Ditriana

Creative Commons License

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

  1. The authors own the copyright of published articles. Nevertheless, Jurnal Respirologi Indonesia has the first-to-publish license for the publication material.
  2. Jurnal Respirologi Indonesia has the right to archive, change the format and republish published articles by presenting the authors’ names.
  3. Articles are published electronically for open access and online for educational, research, and archiving purposes. Jurnal Respirologi Indonesia is not responsible for any copyright issues that might emerge from using any article except for the previous three purposes.

How to Cite

Analysis of Pulmonary Function between E-Cigarette Users and Non-Smokers Aged 20–30 Years in Jakarta. (2025). Jurnal Respirologi Indonesia, 45(2), 127–135. https://doi.org/10.36497/jri.v45i2.791

Similar Articles

1-10 of 276

You may also start an advanced similarity search for this article.